海外の治験の状況「1」での検索結果
1037件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1 Diabetes
- Type 1 Diabetes;Type 1 Diabetes;Type 1 Diabetes
- Australia, New Zealand
- 2006-06-12
Not recruiting
- Polymorphisms in the Human Matrix Metalloproteinase Genes MMP1, MMP3, and MMP9: Genetic Risk Factors of Primary Open Angle Glaucoma?
- Glaucoma
- Austria
- 2006-04-06
Not Recruiting
- ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line use of Canakinumab
- Active systemic manifestations of Systemic Juvenile Idiopathic Arthritis (SJIA) MedDRA version: 19.0 Level: PT Classification code 10059176 Term: Juvenile idiopathic arthritis System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders ;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
- Argentina, Austria, Belgium, Brazil, Canada, France, Germany, Hong Kong, Hungary, Israel, Italy, Mexico, Netherlands, Peru, Poland, Russian Federation, Spain, Sweden, Turkey, United States
- 2014-07-25
Not recruiting
- Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021)
- Human Immunodeficiency Virus (HIV);Human Immunodeficiency Virus (HIV);Human Immunodeficiency Virus (HIV)
- Australia, Belgium, Canada, Chile, Colombia, Denmark, Germany, Guatemala, Honduras, Israel, Mexico, Netherlands, New Zealand, Peru, Portugal, Puerto Rico, Russian Federation, South Africa, Spain, Switzerland, Taiwan, Thailand, United Kingdom, United States
- 2015-03-26
Not recruiting
- Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
- Neurofibromatosis Type 1;Recurrent Childhood Pilocytic Astrocytoma;Recurrent Childhood Visual Pathway Glioma
- Australia, Canada, New Zealand, United States
- 2012-03-10
Not recruiting
- Influence of In-line Microfilters on Systemic Inflammation in Adult Critically Ill Patients
- Systemic Inflammation
- Austria
- 2012-02-09
Not Recruiting
- Pembrolizumab plus epacadostat, pembrolizumab monotherapy, and the EXTREME regimen as first line treatment for R/M HNSCC (KEYNOTE-669/ECHO-304)
- Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma MedDRA version: 20.0 Level: PT Classification code 10060121 Term: Squamous cell carcinoma of head and neck System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Austria, Brazil, Canada, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Spain, Taiwan, Turkey, United Kingdom, United States
- 2017-10-10
Not recruiting
- Avelumab in First-line Non-Small Cell Lung Cancer (JAVELIN Lung 100)
- First Line Non-Small Cell Lung Cancer
- Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Czechia, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Lebanon, Lithuania, Mexico, Netherlands, New Zealand, Peru, Poland, Portugal, Romania, Russian Federation, Serbia, Singapore, Slovakia, South Africa, Spain, Taiwan, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2015-10-13
Not recruiting
- Phase II, 2nd Line Melanoma - RAND Monotherapy
- Melanoma
- Austria, Brazil, Canada, Denmark, France, Germany, Italy, United States
- 2008-01-30
Not recruiting
- Role of Endothelin-1 in Optic Nerve Head Blood Flow Regulation During Isometric Exercise in Healthy Humans
- Healthy
- Austria
- 2009-06-01